For rearch and institution only specification: 10 vials per box different concentration to choose retatrutide is a synthetic peptide composed of 39 amino acids and represents a new generation of metabolic therapy known as a triple receptor agonist. It simultaneously activates the glp-1 glucagon-like peptide-1 , gip glucose-dependent insulinotropic polypeptide , and glucagon receptors, providing complementary mechanisms for weight management and metabolic health. Functions and mechanism of action 1. Glp-1 receptor activation reduces appetite and food intake by promoting satiety. Slows gastric emptying, helping individuals feel full for longer periods. Enhances glucose-dependent insulin secretion, supporting blood sugar control. 2. Gip receptor activation improves insulin sensitivity and glucose metabolism. Works synergistically with glp-1 to enhance glycemic control. May contribute to improved energy utilization and metabolic efficiency. 3. Glucagon receptor activation increases energy expenditure and calorie burning. Promotes fat mobilization and oxidation. Supports greater reductions in body fat when combined with appetite suppression. Potential benefits by targeting all three pathways simultaneously, retatrutide is designed to: achieve significant and sustained weight loss. Improve glycemic control in individuals with obesity or type 2 diabetes. Enhance metabolic flexibility and energy expenditure. Reduce body fat while helping preserve lean body mass. Support overall c...
NasvitaWebDelivery 1-4 days$ 240.00